Paediatric Common Infections Pathways: improving antimicrobial stewardship and promoting ambulation for children presenting with common infections to hospitals in the UK and Ireland.


Journal

JAC-antimicrobial resistance
ISSN: 2632-1823
Titre abrégé: JAC Antimicrob Resist
Pays: England
ID NLM: 101765283

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 18 12 2020
accepted: 15 02 2021
entrez: 5 7 2021
pubmed: 6 7 2021
medline: 6 7 2021
Statut: epublish

Résumé

Paediatric common infection pathways have been developed in collaboration between the BSAC and national paediatric groups, addressing the management of cellulitis, lymphadenitis/lymph node abscess, pneumonia/pleural empyema, pyelonephritis, tonsillitis/peritonsillar abscess, otitis media/mastoiditis, pre-septal/post-septal (orbital) cellulitis, and meningitis. Guidance for the management of a child presenting with a petechial/purpuric rash and the infant under 3 months of age with fever is also provided. The aim of these pathways is to support the delivery of high-quality infection management in children presenting to a hospital. The pathways focus on diagnostic approaches, including the recognition of red flags suggesting complex or severe infection requiring urgent intervention, approaches to antimicrobial stewardship (AMS) principles and guidance on safe and timely ambulation aligned with good practice of outpatient parenteral antimicrobial therapy (OPAT).

Identifiants

pubmed: 34223103
doi: 10.1093/jacamr/dlab029
pii: dlab029
pmc: PMC8210287
doi:

Types de publication

Journal Article

Langues

eng

Pagination

dlab029

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.

Références

BMJ Open. 2016 Nov 3;6(11):e012675
pubmed: 27810974
Arch Dis Child. 2020 Dec;105(12):1220-1228
pubmed: 32381516
Clin Microbiol Rev. 2005 Oct;18(4):638-56
pubmed: 16223951
J Pediatr. 2019 Jan;204:172-176.e1
pubmed: 30293642
Lancet Infect Dis. 2016 Aug;16(8):e139-52
pubmed: 27321363
PLoS One. 2014 Mar 19;9(3):e92206
pubmed: 24647339
J Hosp Infect. 2020 Aug;105(4):736-740
pubmed: 32454075
Infect Control Hosp Epidemiol. 2015 Feb;36(2):222-4
pubmed: 25633007
Pediatrics. 2017 Apr;139(4):
pubmed: 28275204
Clin Pediatr (Phila). 2014 Sep;53(10):1000-3
pubmed: 24198317
Infect Dis Clin North Am. 2018 Mar;32(1):1-17
pubmed: 29406971
J Antimicrob Chemother. 2015 Feb;70(2):360-73
pubmed: 25331058
Pediatr Emerg Care. 2020 May;36(5):e247-e253
pubmed: 28697159
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
J Hosp Infect. 2019 Apr;101(4):426-427
pubmed: 30826342
Lancet Infect Dis. 2017 Dec;17(12):1230-1231
pubmed: 29133171
Arch Dis Child. 2018 Feb;103(2):165-169
pubmed: 28847879
J Pediatric Infect Dis Soc. 2017 Sep 1;6(3):e36-e40
pubmed: 28903514

Auteurs

Carolyne Horner (C)

The British Society for Antimicrobial Chemotherapy, Birmingham, UK.

Robert Cunney (R)

Temple Street Children's University Hospital, Dublin, Ireland.

Alicia Demirjian (A)

Evelina London Children's Hospital, London, UK.

Conor Doherty (C)

Royal Hospital for Children, Glasgow, UK.

Helen Green (H)

Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Mathew Mathai (M)

Bradford Teaching Hospitals NHS Trust, Bradford, UK.

Paddy McMaster (P)

North Manchester General Hospital, Manchester, UK.

Alasdair Munro (A)

Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Stéphane Paulus (S)

Children's Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.

Damian Roland (D)

University of Leicester NHS Trust, Leicester, UK.

Sanjay Patel (S)

The British Society for Antimicrobial Chemotherapy, Birmingham, UK.
Southampton Children's Hospital, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

Classifications MeSH